Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Swanson

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
The AAPS Journal|September 28, 2023
Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay PerformanceXinyuan Li, Shan He, Jaya Thomas, et al.
Open Forum Infectious Diseases|April 16, 2024
1159BanLec, a banana lectin, is a potent inhibitor of Middle East respiratory syndrome coronavirus in <i>in vitro</i> assaysJasper Chan, Kwok-Hung Chan, Dan Boudreaux, et al.
Chemical Communications (Cambridge, England)|May 19, 2005
Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groupsAbir L Banerjee, Shakila Tobwala, Manas K Haldar, et al.
Journal of the American Chemical Society|September 2, 2004
Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-IIAbir L Banerjee, Michael Swanson, Bidhan C Roy, et al.
Journal of the American Chemical Society|October 14, 2004
Two-prong inhibitors for human carbonic anhydrase IIBidhan C Roy, Abir L Banerjee, Michael Swanson, et al.
Clinical Pharmacology and Therapeutics|March 7, 2024
Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene TherapyJennifer Lynn Ford, Eleni Karatza, Hardik Mody, et al.
Biotechnology and Bioengineering|April 19, 2022
Holistic analytical characterization and risk assessment of residual host cell protein impurities in an active pharmaceutical ingredient synthesized by biocatalystsFengqiang Wang, Xuanwen Li, Michael Swanson, et al.
Bioanalysis|July 29, 2023
Phage-derived anti-idiotype and anti-YTE antibodies in development of MK-1654 pharmacokinetic and immune response assaysApril Li, Michael Swanson, Nicole Sullivan, et al.
Biotechnology Progress|January 21, 2021
Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody productXuanwen Li, Yan An, Jing Liao, et al.
Pediatric Neurology|April 2, 2017
X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic AcidEmmanuel Scalais, Elise Osterheld, Christiane Weitzel, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
The AAPS Journal|September 28, 2023
Optimization of Peripheral Blood Mononuclear Cell Processing for Improved Clinical ELISpot Assay PerformanceXinyuan Li, Shan He, Jaya Thomas, et al.
Open Forum Infectious Diseases|April 16, 2024
1159BanLec, a banana lectin, is a potent inhibitor of Middle East respiratory syndrome coronavirus in <i>in vitro</i> assaysJasper Chan, Kwok-Hung Chan, Dan Boudreaux, et al.
Chemical Communications (Cambridge, England)|May 19, 2005
Inhibition of matrix metalloproteinase-9 by "multi-prong" surface binding groupsAbir L Banerjee, Shakila Tobwala, Manas K Haldar, et al.
Journal of the American Chemical Society|September 2, 2004
Protein surface-assisted enhancement in the binding affinity of an inhibitor for recombinant human carbonic anhydrase-IIAbir L Banerjee, Michael Swanson, Bidhan C Roy, et al.
Journal of the American Chemical Society|October 14, 2004
Two-prong inhibitors for human carbonic anhydrase IIBidhan C Roy, Abir L Banerjee, Michael Swanson, et al.
Clinical Pharmacology and Therapeutics|March 7, 2024
Clinical Pharmacology Perspective on Development of Adeno-Associated Virus Vector-Based Retina Gene TherapyJennifer Lynn Ford, Eleni Karatza, Hardik Mody, et al.
Biotechnology and Bioengineering|April 19, 2022
Holistic analytical characterization and risk assessment of residual host cell protein impurities in an active pharmaceutical ingredient synthesized by biocatalystsFengqiang Wang, Xuanwen Li, Michael Swanson, et al.
Bioanalysis|July 29, 2023
Phage-derived anti-idiotype and anti-YTE antibodies in development of MK-1654 pharmacokinetic and immune response assaysApril Li, Michael Swanson, Nicole Sullivan, et al.
Biotechnology Progress|January 21, 2021
Identification and characterization of a residual host cell protein hexosaminidase B associated with N-glycan degradation during the stability study of a therapeutic recombinant monoclonal antibody productXuanwen Li, Yan An, Jing Liao, et al.
Pediatric Neurology|April 2, 2017
X-Linked Cobalamin Disorder (HCFC1) Mimicking Nonketotic Hyperglycinemia With Increased Both Cerebrospinal Fluid Glycine and Methylmalonic AcidEmmanuel Scalais, Elise Osterheld, Christiane Weitzel, et al.
Pageof 3